Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

499 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients.
Malighetti F, Arosio G, Manfroni C, Mauri M, Villa M, Manghisi B, Inzoli E, Rindone G, Zambrotta GPM, Civettini I, Guglielmana V, Ramazzotti D, Giudici G, Bombelli S, Perego R, Piazza R, Mologni L, Gambacorti-Passerini C. Malighetti F, et al. Among authors: piazza r. Hemasphere. 2023 Feb 24;7(3):e852. doi: 10.1097/HS9.0000000000000852. eCollection 2023 Mar. Hemasphere. 2023. PMID: 36860269 Free PMC article. No abstract available.
The achievement of durable complete cytogenetic remission in late chronic and accelerated phase patients with CML treated with Imatinib mesylate predicts for prolonged response at 6 years.
Piazza RG, Magistroni V, Franceschino A, Andreoni F, Tornaghi L, Colnaghi F, Corneo G, Pogliani EM, Gambacorti-Passerini C. Piazza RG, et al. Blood Cells Mol Dis. 2006 Sep-Oct;37(2):111-5. doi: 10.1016/j.bcmd.2006.06.002. Epub 2006 Aug 14. Blood Cells Mol Dis. 2006. PMID: 16908206 Clinical Trial.
Valproic acid enhances bosutinib cytotoxicity in colon cancer cells.
Mologni L, Cleris L, Magistroni V, Piazza R, Boschelli F, Formelli F, Gambacorti-Passerini C. Mologni L, et al. Among authors: piazza r. Int J Cancer. 2009 Apr 15;124(8):1990-6. doi: 10.1002/ijc.24158. Int J Cancer. 2009. PMID: 19123474 Free article.
Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib.
Gambacorti-Passerini C, Antolini L, Mahon FX, Guilhot F, Deininger M, Fava C, Nagler A, Della Casa CM, Morra E, Abruzzese E, D'Emilio A, Stagno F, le Coutre P, Hurtado-Monroy R, Santini V, Martino B, Pane F, Piccin A, Giraldo P, Assouline S, Durosinmi MA, Leeksma O, Pogliani EM, Puttini M, Jang E, Reiffers J, Piazza R, Valsecchi MG, Kim DW. Gambacorti-Passerini C, et al. Among authors: piazza r. J Natl Cancer Inst. 2011 Apr 6;103(7):553-61. doi: 10.1093/jnci/djr060. Epub 2011 Mar 21. J Natl Cancer Inst. 2011. PMID: 21422402 Clinical Trial.
499 results